| Phone | 615.936.7032 |
| Office | 383 PRB Nashville, TN 37232 |
| charles.c.hong@vanderbilt.edu | |
 |
|
|
Fig.
2. Schema of zebrafish-based structure-activity relationship (SAR) study of DM analogues. Excerpted from In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. |
|
|
The Hong laboratory research focuses on four areas:
|
|
NEWEST PUBLICATIONS SFRP2 suppression of BMP and WNT signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. Serial observations and mutational analysis of an adoptee with family history of hypertrophic cardiomyopathy. |
| PREVIOUS PUBLICATIONS |
| For more information about Dr. Hong visit his Vanderbilt Faculty Page or his Lab Web Page |
Vanderbilt University is committed
to principles of equal opportunity and affirmative action
Copyright 2004, Educational
Technology, Biomedical Research Education & Training
Last modified: Wednesday,October 6,
2010 by Kim.Kane@vanderbilt.edu